基于生物信息学及分子对接技术探究杜仲总黄酮治疗多囊卵巢综合征的作用机制
Exploring the Mechanism of Action of Total Flavonoids from Eucommia ulmoides in the Treatment of Polycystic Ovary Syndrome Based on Bioinformatics and Molecular Docking Technology
摘要: 研究旨在通过生物信息学与分子对接技术,探究杜仲总黄酮(TFE)治疗多囊卵巢综合征(PCOS)的潜在作用机制。研究人员首先从GEO数据库获取PCOS相关的转录组数据集(GSE277906),筛选出差异表达基因(DEGs)。其次,对DEGs进行GO功能注释和KEGG通路富集分析,并构建蛋白质–蛋白质相互作用(PPI)网络。基于PPI网络分析,筛选出关键靶基因PECAM1、CD5和KLRB1。最后,采用分子对接技术验证了杜仲总黄酮(TFE)与这三个关键靶蛋白的结合能力。研究结果显示,TFE可能通过调控与免疫炎症(如白细胞黏附与迁移)和代谢(如胰岛素抵抗、类固醇激素生物合成)相关的信号通路,作用于PECAM1、CD5、KLRB1等核心靶点,从而发挥治疗PCOS的多靶点协同效应。
Abstract: This study aims to investigate the potential mechanism of total flavonoids from Eucommia ulmoides (TFE) in the treatment of polycystic ovary syndrome (PCOS) using bioinformatics and molecular docking approaches. Researchers first retrieved PCOS-related transcriptomic datasets (GSE277906) from the GEO database and screened differentially expressed genes (DEGs). Subsequently, GO functional annotation and KEGG pathway enrichment analyses were performed on the DEGs, followed by the construction of a protein-protein interaction (PPI) network. Based on PPI network analysis, three core target genes—PECAM1, CD5, and KLRB1—were identified. Finally, molecular docking was employed to validate the binding affinity between TFE and these three key target proteins. The results suggest that TFE may exert multi-target synergistic effects in treating PCOS by modulating signaling pathways associated with immune inflammation (e.g., leukocyte adhesion and migration) and metabolism (e.g., insulin resistance and steroid hormone biosynthesis), primarily acting on core targets including PECAM1, CD5, and KLRB1.
文章引用:易晓英, 周子涵, 赵婷, 赵妤欣, 陈灿, 贾元斌, 龙艳慧. 基于生物信息学及分子对接技术探究杜仲总黄酮治疗多囊卵巢综合征的作用机制[J]. 中医学, 2026, 15(4): 490-501. https://doi.org/10.12677/tcm.2026.154236

参考文献

[1] 王丽丽. 多囊卵巢大鼠卵巢组织中LIF和VEGF的表达及意义[D]: [硕士学位论文]. 大连: 大连医科大学, 2008.
[2] 梁新新, 林睿. 二甲双胍联合戊酸雌二醇、克罗米芬治疗多囊卵巢综合征所致不孕症对患者胰岛素、胰岛素抵抗指数水平及卵巢排卵功能的影响[J]. 陕西医学杂志, 2023, 52(4): 460-463.
[3] Tsiami, A.P., Goulis, D.G., Sotiriadis, A.I. and Kolibianakis, E.M. (2021) Higher Ovulation Rate with Letrozole as Compared with Clomiphene Citrate in Infertile Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Hormones (Athens), 20, 449-461. [Google Scholar] [CrossRef] [PubMed]
[4] 刘冬梅, 王杰杰, 张金玲, 等. 多囊卵巢综合征不孕患者血清促肾上腺皮质激素 抗苗勒管激素与性激素和妊娠结局的关系[J]. 中国妇幼保健, 2025, 40(4): 680-683.
[5] 毕晓英, 许珂, 赵艳晓, 等. 基于PI3K/AKT/mTOR通路研究杜仲总黄酮对多囊卵巢综合征大鼠性激素水平及卵巢组织自噬的影响[J]. 中药药理与临床, 2022, 38(1): 82-86.
[6] 董双千, 汤怡倩, 徐浩田, 等. 启宫丸对多囊卵巢综合征-胰岛素抵抗大鼠AdipoR/AMPK信号通路的影响[J]. 中成药, 2025, 47(2): 584-589.
[7] 屠豪炎. 达英-35联合二甲双胍改善PCOS大鼠卵泡发育的能量代谢调控的初步研究[D]: [硕士学位论文]. 桂林: 桂林医学院, 2019.
[8] Matsuda, M. and Hirata, M. (2017) Phospholipase C-Related but Catalytically Inactive Proteins Regulate Ovarian Follicle Development. Journal of Biological Chemistry, 292, 8369-8380. [Google Scholar] [CrossRef] [PubMed]
[9] Harris, S.E., Maruthini, D., Tang, T., Balen, A.H. and Picton, H.M. (2010) Metabolism and Karyotype Analysis of Oocytes from Patients with Polycystic Ovary Syndrome. Human Reproduction, 25, 2305-2315. [Google Scholar] [CrossRef] [PubMed]
[10] Yoshino, J., Mills, K.F., Yoon, M.J. and Imai, S. (2011) Nicotinamide Mononucleotide, a Key NAD(+) Intermediate, Treats the Pathophysiology of Diet-and Age-Induced Diabetes in Mice. Cell Metabolism, 14, 528-536. [Google Scholar] [CrossRef] [PubMed]
[11] Bertoldo, M.J., Uddin, G.M., Youngson, N.A., Agapiou, D., Walters, K.A., Sinclair, D.A., et al. (2018) Multigenerational Obesity-Induced Perturbations in Oocyte-Secreted Factor Signalling Can Be Ameliorated by Exercise and Nicotinamide Mononucleotide. Human Reproduction Open, 2018, hoy010. [Google Scholar] [CrossRef] [PubMed]
[12] Yamaguchi, S. and Yoshino, J. (2017) Adipose Tissue NAD(+) Biology in Obesity and Insulin Resistance: From Mechanism to Therapy. BioEssays, 39, Article ID: 1600227. [Google Scholar] [CrossRef] [PubMed]
[13] Nadtochiy, S.M., Wang, Y.T., Nehrke, K., Munger, J. and Brookes, P.S. (2018) Cardioprotection by Nicotinamide Mononucleotide (NMN): Involvement of Glycolysis and Acidic pH. Journal of Molecular and Cellular Cardiology, 121, 155-162. [Google Scholar] [CrossRef] [PubMed]
[14] 赵珊珊, 韩亚鹏, 潘紫萌, 等. 基于PI3K/Akt信号通路探究中医药治疗胰岛素抵抗型多囊卵巢综合征的研究进展[J]. 辽宁中医杂志, 2022, 49(11): 211-216.
[15] Pepene, C.E. (2012) Soluble Platelet/Endothelial Cell Adhesion Molecule (sPECAM)-1 Is Increased in Polycystic Ovary Syndrome and Related to Endothelial Dysfunction. Gynecological Endocrinology, 28, 370-374. [Google Scholar] [CrossRef] [PubMed]
[16] Wang, J., Wu, D., Guo, H. and Li, M. (2019) Hyperandrogenemia and Insulin Resistance: The Chief Culprit of Polycystic Ovary Syndrome. Life Sciences, 236, Article ID: 116940. [Google Scholar] [CrossRef] [PubMed]
[17] 达晶, 赵珊珊, 匡洪影. 植物黄酮防治多囊卵巢综合征研究进展[J]. 中医学报, 2024, 39(3): 555-561.
[18] 宋红新. 基于网络药理学的黄芩汤调控UC模型小鼠Th17/Treg、Th1/Th2细胞平衡的免疫学机制研究[D]: [硕士学位论文]. 北京: 中国中医科学院, 2021.
[19] 贺欣, 邢莉民, 邵宗鸿. CD5及其在自身免疫性疾病中的作用研究进展[J]. 中国免疫学杂志, 2020, 36(14): 1766-1770.